Cleared Traditional

K872346 - SURE-STREP A TEST KIT CATALOG NO. MB-1083

K872346 is an FDA 510(k) clearance for SURE-STREP A TEST KIT CATALOG NO. MB-1083, manufactured by Medix Biotech, Inc.. The device is a Class 1 Microbiology device with product code GTZ cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K872346 · Medix Biotech, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1987
Decision
105d
Days
Class 1
Risk

K872346 is an FDA 510(k) clearance for the SURE-STREP A TEST KIT CATALOG NO. MB-1083. Classified as Antisera, All Groups, Streptococcus Spp. (product code GTZ), Class I - General Controls.

Submitted by Medix Biotech, Inc. (Foster City, US). The FDA issued a Cleared decision on September 30, 1987 after a review of 105 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medix Biotech, Inc. devices

FDA 510(k) Submission Details - K872346

510(k) Number K872346 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 17, 1987
Decision Date September 30, 1987
Days to Decision 105 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d slower than avg
Panel avg: 102d · This submission: 105d
Pathway characteristics
Predicate-based equivalence.

GTZ Device Classification - Class 1, General Controls

Product Code GTZ Antisera, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTZ Antisera, All Groups, Streptococcus Spp.

All 89
Devices cleared under the same product code (GTZ) and FDA review panel - the closest regulatory comparables to K872346.
V-TREND STREP A TEST
K880483 · Texas Immunology, Inc. · Apr 1988
TARGET STREP A
K880460 · V-Tech, Inc. · Mar 1988
BINAX EQUATE STREP B
K872904 · Binax, Inc. · Nov 1987
QTEST STREP
K872961 · Quidel Corp. · Sep 1987
BACTIGEN GROUP B STREPTOCOCCUS-CS TEST
K872114 · Armkel, LLC · Aug 1987
DIRECTIGEN 1-2-3(TM) GROUP A STREP TEST
K872493 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1987